000 | 01256 a2200337 4500 | ||
---|---|---|---|
005 | 20250517200128.0 | ||
264 | 0 | _c20180507 | |
008 | 201805s 0 0 eng d | ||
022 | _a1473-5741 | ||
024 | 7 |
_a10.1097/CAD.0000000000000591 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBayati, Samaneh | |
245 | 0 | 0 |
_aAntileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant. _h[electronic resource] |
260 |
_bAnti-cancer drugs _c03 2018 |
||
300 |
_a243-252 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAprepitant |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aNeurokinin-1 Receptor Antagonists _xpharmacology |
650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xmetabolism |
700 | 1 | _aRazani, Elham | |
700 | 1 | _aBashash, Davood | |
700 | 1 | _aSafaroghli-Azar, Ava | |
700 | 1 | _aSafa, Majid | |
700 | 1 | _aGhaffari, Seyed H | |
773 | 0 |
_tAnti-cancer drugs _gvol. 29 _gno. 3 _gp. 243-252 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000591 _zAvailable from publisher's website |
999 |
_c28033471 _d28033471 |